from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3585/radA

LFCtreatmentdescriptionclass of inhibitor

0.820

Amikacinug/mL Amikacintranslation

0.091

Cap5-10ug/mL Capreomycintranslation

0.438

Rox10-50 ug/mL Roxithromycintranslation

0.409

SM2-5 ug/mL Streptomycintranslation

1.704

Tet5-10 ug/mL Tetracyclinetranslation

0.330

Rif0.2-5ug/mL Rifampicintranscription

-0.415

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.003

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.870

CPZ10-50 ug/mL Chlorpromazinerespiration

0.595

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.722

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.477

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.238

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.179

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.804

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.017

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.905

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.061

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.718

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.716

KCN5-20 ug/mL Potassium cyaniderespiration

-0.535

NaN30.2-2 mM Sodium aziderespiration

-0.636

Nigericin50 uM Nigericinrespiration

0.027

TRC10-150 ug/mL Triclosanrespiration

-0.757

TRZ10-25 ug/mL Thioridazinerespiration

0.889

Valinomycin0.5-10 uM Valinomycinrespiration

2.021

ZnSO42 mM ZnSO4respiration

0.551

menadione6-10 ug/mL Menadionerespiration

-0.395

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.645

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.841

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.612

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.244

NRP_1Non-replicating persistence stage 1dosRassociated

-0.570

Amp0.2mg/mL AmpicillincellWall

-0.468

Cephalexin20-100 ug/mL CephalexincellWall

-0.660

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.207

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.178

EMB10-20 ug/mL EthambutolcellWall

-0.227

Eta12-40 ug/mL EthionamidecellWall

-0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.314

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.050

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.765

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.600

BZA0.12 mg/mL BenzamidearomaticAmides

0.348

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.216

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.401

H2O24 mM hydrogen peroxideDNAdamaging

1.491

Levo10 ug/mL LevofloxacinDNAdamaging

0.776

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.420

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.180

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.818

UVUV-irradiationDNAdamaging

-0.010

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.780

Antimycin12.5-50 ug/mL Antimycin A?

-0.770

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.220

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.452

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.516

PA8240.2-2 ug/mL PA-824?

0.013

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.238

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.858

Verapamil50 uM Verapamil?

-0.132

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.646

methoxatin10-20 ug/mL Methoxatin?